Bladder cancer: Biomarker panel predicts recurrence after radical cystectomy

Nature Reviews Urology

Volumn 10, Issue 6, 2013, Pages 309-

  Payton, Sarah ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; KI 67 ANTIGEN; MOLECULAR MARKER; PROTEIN P53;

BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CELL CYCLE REGULATION; CELL PROLIFERATION; CLINICAL PRACTICE; CYSTECTOMY; HUMAN; IMMUNOHISTOLOGY; LYMPH NODE DISSECTION; LYMPH VESSEL METASTASIS; MUSCLE INVASIVE BLADDER CANCER; NOTE; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL MARKERS; CYSTECTOMY; HUMANS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84880293190     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2013.95     Document Type: Note

References (1)

1. Lotan, Y. et al. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy. Eur. Urol. doi:10.1016/j.eururo.2013.03.043